2025³â 08¿ù 07ÀÏ ¸ñ¿äÀÏ
 
 
  ÇöÀçÀ§Ä¡ > Àαⴺ½º

·£¼¶¿þ¾îºÎÅÍ µÅÁöµµ»ì±îÁö... ³ë·ÃÇØÁø »ç±âÇà°¢

 

Á¤Ä¡

 

°æÁ¦

 

»çȸ

 

»ýȰ

 

¹®È­

 

±¹Á¦

 

°úÇбâ¼ú

 

¿¬¿¹

 

½ºÆ÷Ã÷

 

ÀÚµ¿Â÷

 

ºÎµ¿»ê

 

°æ¿µ

 

¿µ¾÷

 

¹Ìµð¾î

 

½Å»óǰ

 

±³À°

 

ÇÐȸ

 

½Å°£

 

°øÁö»çÇ×

 

Ä®·³

 

Ä·ÆäÀÎ
Çѻ츲 ¡®¿ì¸®´Â ÇѽҸ²¡¯ ½Ò ¼Òºñ Ä·ÆäÀÎ ½Ã...
1000¸¸¿øÂ¥¸® Àΰø¿Í¿ì, °Ç°­º¸Çè Áö¿ø ¡®Æò...
 
¸ðµÎ 92542°³ÀÇ ´º½º°¡ °Ë»öµÇ¾ú½À´Ï´Ù.



ÅÂÇ×È£, MBC ¡®¸Þ¸® ųÁî ÇÇÇᯠÃ⿬

ºÎÇü»ç·Î º¯½Å, Á¶·Â»ç¸Á »ç°Ç ÃßÀû
¹è¿ì ÅÂÇ×È£°¡ Áö³­ 1ÀÏ Ã¹ ¹æ¼ÛµÈ MBC ±ÝÅäµå¶ó¸¶ ‘¸Þ¸® ųÁî ÇÇÇÃ’(±âȹ ±Ç¼ºÃ¢ / ¿¬Ãâ ¹ÚÁØ¿ì / ±Øº» À̼ö¾Æ / Á¦ÀÛ ¹Ì½ºÅͷθǽº, ¹«ºùÇÈÃĽºÄÄÆÛ´Ï, ½ºÆ©µð¿À ¾ÈÀÚÀÏ·»)À» ÅëÇØ ½ÃûÀÚµé°ú ¸¸³µ´Ù.   ‘¸Þ¸® ųÁî ÇÇÇÃ’Àº Ä¡·á°¡ ºÒ°¡´ÉÇÑ È¯ÀÚµéÀÇ Á¶·Â »ç¸ÁÀ» µ½´Â ÀÇ»ç¿Í À̸¦ ÃßÀûÇÏ´Â Çü»çÀÇ À̾߱⸦ ±×¸° ¼­½ºÆæ½º µå¶ó¸¶´Ù.   ±Ø Áß ÅÂÇ×È£´Â ±¤¼ö´ëÀå żº(±èÅÂ¿ì ºÐ)°ú ÇÔ²² »ç°ÇÀ» ÂÑ´Â ‘ºÎÇü»ç’·Î ºÐÇØ, Á¶·Â »ç¸Á »ç°ÇÀÇ ½Çü¿¡ ´Ù°¡¼­±â À§ÇØ ÇöÀåÀ» ´©ºñ°í ´Ü¼­¸¦ ...

KGM, Áö´ÉÇüÀÚµ¿Â÷ºÎǰÁøÈï¿ø°ú ÀÚÀ²ÁÖÇà ±â¼úÇù·Â MOU

ÀÚÀ²ÁÖÇà °ü·Ã À¯·´ ¹ý±Ô ´ëÀÀÀº ¹°·Ð ¾ç»ê ±â¼ú È®º¸ ±â´ë
KG ¸ðºô¸®Æ¼(ÀÌÇÏ KGM)°¡ Áö´ÉÇüÀÚµ¿Â÷ºÎǰÁøÈï¿ø (ÀÌÇÏ ÁøÈï¿ø)°ú ÀÚÀ²ÁÖÇà ±â¼ú °³¹ß MOU¸¦ ü°áÇÏ°í »óÈ£Çù·ÂÇϱâ·Î Çß´Ù. Áö³­ 28ÀÏ(¿ù) ÁøÈï¿ø º»»ç(´ë±¸½Ã ´Þ¼º±º ¼ÒÀç)¿¡¼­ ¿­¸° MOU ü°á½Ä¿¡´Â KGM ±Ç¿ëÀÏ ±â¼ú¿¬±¸¼Ò ¼ÒÀå°ú ÁøÈï¿ø ¼­ÀçÇü ¿øÀåÀ» ºñ·ÔÇÑ °ü°èÀÚµéÀÌ Âü¼®Çß´Ù. ÁøÈï¿øÀº ÀÚÀ²ÁÖÇàÂ÷ µî Â÷¼¼´ë ÀÚµ¿Â÷ ±â¼úÀ» °³¹ßÇÏ´Â °ü·Ã ¾÷ü¿Í ¿¬±¸±â°üÀ» Áö¿øÇϱâ À§ÇØ 2014³â ¼³¸³µÈ ½ÃÇè Àü¹® ±â°üÀ¸·Î, °í¼Ó ÁÖȸ·Î, ¹ü¿ë ½ÃÇè·Î µî ´Ù¾çÇÑ Á¶°Ç¿¡¼­ÀÇ ÀÚµ¿Â÷ ÁÖÇà ½ÃÇè ¹× Ãæ°Ý ³»±¸ ½ÃÇè Àåºñ µîÀÇ ½Ã¼³ ¹× ½ÃÇè Àη ...

Novotech Report: How In-Vivo CAR-T May Reshape Cell Therapy Econo...
SYDNEY -- With in-vivo CAR-T therapies gaining global momentum, a new whitepaper from Novotech, a leading global full-service clinical Contract Research Organization (CRO) and scientific advisory company, offers insight into this next frontier of immunotherapy. In-Vivo CAR Therapies - Global Research and Development Landscape (2025) report explores the accelerating innovation in in-vivo CAR-T (Chimeric Antigen Receptor) technologies and their potential to reshape treatment across oncology, autoi ...
ÀÏ·ë, ½ÄŹ ½ÅÁ¦Ç° 2Á¾ Ãâ½Ã (2025-07-02)
T1, º£Æ®³² ÆÒ´ý È®Àå À§ÇØ ÄÉÀ̵ðÄí¿Í ¼ÕÀâ´Ù (2025-07-18)
¡®µÎÀ¯³ëÁý¹ä¡¯ ÀÌÀå¿ì, ¡°»ìÂ𠸸ŭ ¿ä¸®°¡ ´Ã¾î~¡± (2025-07-07)
»ï¾çÄÉÀ̾¾¾ÆÀÌ, °í±â´É¼º È­Àåǰ ¿ø·á ¼±º¸¿© (2025-07-05)
ÇÑÀü-º¥Ã÷, Àü±âÂ÷ Plug & Charge È®»ê¿¡ ¾ÕÀå¼±´Ù (2025-07-13)
Andersen Consulting Advances Cybersecurity Presence with 10G... (2025-07-21)
NETSCOUT Advances AI-Driven Network Operations for TM Forum... (2025-07-26)
Software-Defined Networks Aid Firms¡¯ Agility in Asia Pacifi... (2025-07-28)
LG Announces Ambition To Become Top-Tier Global HVAC Solutio... (2025-07-23)
LG Releases Preliminary Earnings for Second-Quarter 2025 (2025-07-27)
CSC Research Finds 40% of Enterprises Could Be at Risk of an... (2025-07-23)
Starfall Requests U.S. Counterintelligence Support to Shield... (2025-07-27)
Lifezone Metals Files the Feasibility Study Technical Report... (2025-07-22)
Zayed Sustainability Prize Sees Surge in Global Participatio... (2025-08-06)
·Ôµ¥°Ç¼³ ¡®°è¾ç ·Ôµ¥Ä³½½ ÆÄÅ©½ÃƼ¡¯ °ßº»ÁÖÅà ¿ÀÇ (2024-04-26)
·¹µåÆäÀ̽º, °£Àý±â ½ºÅ¸ÀÏ ¾÷ÇÏ´Â ¾Æ¿ôµµ¾î ÀçŶ Ãâ½Ã (2025-02-27)
ºê·ç³Ú·Î ÄíÄ¡³Ú¸®, º½-¿©¸§ ½´Áî Ä÷º¼Ç ÆË¾÷ ½ºÅä¾î ¿ÀÇ (2024-05-01)
¼­¿ï½Ã ´ÙÀÚ³à °¡Á¤ À§ÇÑ Çʼö À°¾ÆÅÛ ¡®½ÅÇÑ ´ÙµÕÀÌÇູīµå¡¯ (2025-03-16)
¼­¿ï½Ãû³â¸¶À½°Ç°­¼¾ÅÍ, ¹®Á¦º° Ä¡·áÀû ÇÁ·Î±×·¥ ¿î¿µ (2025-03-29)
µµ¹è ´ÞÀÎÀÇ À̾߱â (2024-04-27)
Æø½º¹Ù°Õ, ¿£Æ®¸®±Þ Àü±âÂ÷ ¡®ID. EVERY1 ÄܼÁÆ®¡¯ °ø°³ (2025-03-07)
AI¿Í ½Ã¹ÎÀÇ À¯ÄèÇÑ Ã¹ ¸¸³²¡¦ ¼­¿ï½Ã ¡®¼­¿ï AI Æä½ºÅ¸¡¯ °³ÃÖ (2025-03-08)
¼¼°è ÃÖÃÊ ½Ã¸àÆ® ¹× ÄÜÅ©¸®Æ®¿ë Àúź¼Ò µî±Þ ½Ã½ºÅÛ Ãâ¹ü (2025-05-25)
¿ì¸®ÀºÇà, ÀÚ»ê°ü¸®Æ¯È­Á¡ ¡®Åõü¾î½ºW¿©Àǵµ¡¯ °³Á¡ (2025-03-18)
¸ðÅä·Î¶ó, '¿§Áö 50 Ç»Àü¡¯ ±¹³» Ãâ½Ã (2024-12-05)
       [ÀÌÀü][1]....[173][174][175][176][177][178][179][180][181]...[3702][´ÙÀ½]

°øÁö»çÇ×
´º½ºÁö ÇÑÀÚ Ç¥±â¿¡ ´ë¸¸½Ä À½Â÷ Ç¥±â '纽ÞÙó¢ ´Ï¿ì½ÃÁö' º´±â
º£³×ÇÁ·Ò º£³×ÀÎÅõ Áß¹® Ç¥±â 宝Ò¬ÜØÙÌ 宝Ò¬ì×öõ(ÜÄÒ¬ÜØÙÌ ÜÄ...
¹Ìµð¾î¾Æ¿ì¾î Mediaour ØÚ体ä²们 ØÚô÷ä²Ùú MO ¿¥¿À ØÚä² ØÚä²
¾Ë¸®¿ìºê Alliuv ä¹备: ä¹联êó备, ¾Ë¶ã Althle ä¹÷åìÌ
¾Ë¸®¾Ë Allial Áß¹® Ç¥±â ä¹××尔 ä¹××ì³
´ºÆÛ½ºÆ® New1st Áß¹® Ç¥±â 纽ììãæ(¹øÃ¼ Òïììãæ), N1 纽1
¿£ÄÚ½º¸ð½º : À̾¾ 'EnCosmos : EC' Áß¹® Ç¥±â ì¤ñµ
¾ÆÀ̵ð¾î·Ð Idearon Áß¹® Ç¥±â ì¤îè论 ì¤îèÖå
¹ÙÀÌ¿ÀÀÌ´Ï Bioini Áß¹® Ç¥±â ù±药研 ù±å·æÚ
¿À½ºÇÁ·Ò Ausfrom 奥ÞÙÜØÙÌ, À£ÇÁ·Ò Welfrom 卫ÜØÙÌ
¿¡³ÊÇÁ·Ò Enerfrom 额ÒöÜØÙÌ ¿¡³ÊÀ¯ºñ Eneruv 额Òöêó备
¾ËÇÁ·Ò Alfrom Áß¹® Ç¥±â ä¹尔ÜØÙÌ ä¹ì³ÜØÙÌ
 

ȸ»ç¼Ò°³ | ÀÎÀçä¿ë | ÀÌ¿ë¾à°ü | °³ÀÎÁ¤º¸Ãë±Þ¹æÄ§ | û¼Ò³âº¸È£Á¤Ã¥ | Ã¥ÀÓÇѰè¿Í ¹ýÀû°íÁö | À̸ÞÀÏÁÖ¼Ò¹«´Ü¼öÁý°ÅºÎ | °í°´¼¾ÅÍ

±â»çÁ¦º¸ À̸ÞÀÏ news@newsji.com, ÀüÈ­ 050 2222 0002, ÆÑ½º 050 2222 0111, ÁÖ¼Ò : ¼­¿ï ±¸·Î±¸ °¡¸¶»ê·Î 27±æ 60 1-37È£

ÀÎÅͳݴº½º¼­ºñ½º»ç¾÷µî·Ï : ¼­¿ï ÀÚ00447, µî·ÏÀÏÀÚ : 2013.12.23., ´º½º¹è¿­ ¹× û¼Ò³âº¸È£ÀÇ Ã¥ÀÓ : ´ëÇ¥ CEO

Copyright ¨Ï All rights reserved..